the Safety and Efficacy of Intravitreal Injection of Tpdelansbsalbac in Malignant Effusions.

Salmonella Bacteremia Clinical Trial

Official title:
A Phase I/II Clinical Study of the Safety and Efficacy of Intravitreal Injection of Tpdelansbsalbac in the Treatment of Malignant Pleural and Abdominal Effusions

Status Recruiting

Clinical Trial Summary

This is a Phase I/II, open, first-in-human (FIH) study of Transebacillus in Patients with malignant pleural and abdominal effusions. It consists of Phase Ia to determine the Maximum tolerated dose (MTD) or Recommended Phase 2 dose (RP2D) of Transebacillus, and Phase Ib/II to explore and confirm the efficacy, safety and Tolerability.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06178003
Study type	Interventional
Source	The First Affiliated Hospital of Xinxiang Medical College
Contact	Yinghua Ji
Phone	13663030446
Email	54234317@qq.com
Status	Recruiting
Phase	N/A
Start date	February 11, 2024
Completion date	January 1, 2025

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04473768` - Clinical Decision Support in Non-typhoidal Salmonella Bloodstream Infections in Children